Prognostic significance of troponin level in 3121 patients presenting with atrial fibrillation (The NIHR Health

Amit Kaura1, Ahran D Arnold1, Vasileios Panoulas1

  • 1NIHR Imperial Biomedical Research Centre Imperial College London and Imperial College Healthcare NHS Trust London United Kingdom.

Insights

Elevated troponin levels in patients with atrial fibrillation (AF) correlate with increased mortality risk. Coronary angiography may mitigate this risk, suggesting coronary artery disease is a key factor.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Biomarkers

Background:

  • Atrial fibrillation (AF) patients often have troponin tests, but the clinical significance of results is unclear.
  • Troponin elevation in AF is common, yet its association with mortality and underlying causes needs clarification.

Purpose of the Study:

  • To investigate the relationship between troponin levels, coronary angiography, and all-cause mortality in AF patients.
  • To determine if coronary artery disease (CAD) mediates the increased mortality risk associated with troponin elevation in AF.

Main Methods:

  • Utilized National Institute of Health Research Health Informatics Collaborative data from 3121 UK tertiary center patients admitted with AF (2010-2017).
  • Analyzed peak troponin levels (scaled as multiples of the upper limit of normal) and their association with all-cause mortality over a median follow-up of 1462 days.
  • Examined the relationship between troponin levels, odds of undergoing coronary angiography, and mortality risk post-angiography.

Main Results:

  • A positive troponin result (above the upper limit of normal) was associated with a 1.20-fold increased hazard ratio for mortality (P<0.05).
  • Higher troponin levels showed an exponential relationship with mortality risk, peaking at approximately 250-fold the upper limit of normal (HR 2.6).
  • Increased troponin levels correlated with higher odds of coronary angiography, which was associated with a 36% lower mortality risk (aHR 0.61, P=0.01).

Conclusions:

  • Elevated troponin levels are linked to increased all-cause mortality in patients presenting with AF.
  • The reduced mortality in patients undergoing coronary angiography suggests that CAD may be the underlying cause of troponin elevation and is potentially treatable with revascularization.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
702
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
150
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
593
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
295
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
301
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
242